haao-1 Antibody

Introduction to HAAO-1 Antibody

The HAAO-1 antibody is a research reagent designed to detect 3-hydroxyanthranilate 3,4-dioxygenase (HAAO), an enzyme involved in tryptophan metabolism. It catalyzes the conversion of 3-hydroxyanthranilic acid (3HAA) to quinolinic acid (QUIN), a neurotoxic compound implicated in neurological disorders . The antibody is used in immunological techniques such as Western blotting (WB), immunohistochemistry (IHC), immunofluorescence (IF/ICC), and enzyme-linked immunosorbent assay (ELISA) to study HAAO’s expression, localization, and functional roles in disease models .

Structure and Function of HAAO-1 Antibody

HAAO-1 antibodies are typically polyclonal or monoclonal, with reactivity primarily in human, mouse, and rat tissues. Key characteristics include:

The antibody binds to HAAO’s cytosolic localization, enabling detection in liver, kidney, pancreas, and gliomas . Its function is critical for studying HAAO’s role in the kynurenine pathway and oxidative stress responses .

Applications and Experimental Uses

HAAO-1 antibodies are validated for diverse experimental approaches:

Protocols emphasize optimizing dilutions and buffer conditions for specificity .

Research Findings and Functional Insights

Recent studies highlight HAAO-1’s role in oxidative stress and aging:

Mechanistic Role in Oxidative Stress

• HAAO-1 knockdown in C. elegans elevates 3HAA levels, activating the Nrf2/SKN-1 pathway and enhancing resistance to reactive oxygen species (ROS) .

• Hormetic effects: Increased endogenous ROS primes cells to handle subsequent oxidative stress, extending lifespan .

Lifespan Extension Models

Pathological Relevance

• Neurological disorders: HAAO’s role in QUIN production links it to excitotoxicity in neurodegenerative diseases .

• Cancer biomarker: Elevated HAAO levels correlate with ovarian cancer, suggesting diagnostic potential .

Disease Association

• Neurological disorders: HAAO-mediated QUIN production contributes to excitotoxicity in conditions like Huntington’s disease and multiple sclerosis .

• Cancer: HAAO overexpression in ovarian cancer suggests its utility as a biomarker .

Therapeutic Potential

• Inhibition strategies: Reducing HAAO activity may mitigate QUIN toxicity while enhancing stress resistance via Nrf2/SKN-1 activation .

• Aging interventions: Modulating the kynurenine pathway (via 3HAA) could delay aging-related oxidative damage .